| EER | ENST | ENSG | GeneName | Region | Repeat | dsRNA structure | | chr17:82109552-82112295:- | ENST00000392346.5 | ENSG00000176155.17 | CCDC57 | UTR3 | AluJb,AluSz6,L1MEh,(A)n,A-rich,AluSx1,AluSp,AluY | chr17:82109552-82112295:-.alignment |
| chr17:82109552-82112295:- | ENST00000419322.5 | ENSG00000176155.17 | CCDC57 | UTR3 | AluJb,AluSz6,L1MEh,(A)n,A-rich,AluSx1,AluSp,AluY | chr17:82109552-82112295:-.alignment |
| chr17:82113704-82113883:- | ENST00000392346.5 | ENSG00000176155.17 | CCDC57 | exonic | AluJb | chr17:82113704-82113883:-.alignment |
| chr17:82113704-82113883:- | ENST00000419322.5 | ENSG00000176155.17 | CCDC57 | exonic | AluJb | chr17:82113704-82113883:-.alignment |
| chr17:82115465-82116118:- | ENST00000389641.7 | ENSG00000176155.17 | CCDC57 | intronic | AluSg4,AluJb,(T)n | chr17:82115465-82116118:-.alignment |
| chr17:82115465-82116118:- | ENST00000392345.5 | ENSG00000176155.17 | CCDC57 | intronic | AluSg4,AluJb,(T)n | chr17:82115465-82116118:-.alignment |
| chr17:82115465-82116118:- | ENST00000392346.5 | ENSG00000176155.17 | CCDC57 | intronic | AluSg4,AluJb,(T)n | chr17:82115465-82116118:-.alignment |
| chr17:82115465-82116118:- | ENST00000392347.4 | ENSG00000176155.17 | CCDC57 | intronic | AluSg4,AluJb,(T)n | chr17:82115465-82116118:-.alignment |
| chr17:82115465-82116118:- | ENST00000419322.5 | ENSG00000176155.17 | CCDC57 | intronic | AluSg4,AluJb,(T)n | chr17:82115465-82116118:-.alignment |
| chr17:82115465-82116118:- | ENST00000583593.2 | ENSG00000176155.17 | CCDC57 | intronic | AluSg4,AluJb,(T)n | chr17:82115465-82116118:-.alignment |
| chr17:82123196-82123429:- | ENST00000389641.7 | ENSG00000176155.17 | CCDC57 | intronic | L1ME4b,AluJo | chr17:82123196-82123429:-.alignment |
| chr17:82123196-82123429:- | ENST00000392345.5 | ENSG00000176155.17 | CCDC57 | intronic | L1ME4b,AluJo | chr17:82123196-82123429:-.alignment |
| chr17:82123196-82123429:- | ENST00000392346.5 | ENSG00000176155.17 | CCDC57 | intronic | L1ME4b,AluJo | chr17:82123196-82123429:-.alignment |
| chr17:82123196-82123429:- | ENST00000392347.4 | ENSG00000176155.17 | CCDC57 | intronic | L1ME4b,AluJo | chr17:82123196-82123429:-.alignment |
| chr17:82123196-82123429:- | ENST00000419322.5 | ENSG00000176155.17 | CCDC57 | intronic | L1ME4b,AluJo | chr17:82123196-82123429:-.alignment |
| chr17:82123196-82123429:- | ENST00000583593.2 | ENSG00000176155.17 | CCDC57 | intronic | L1ME4b,AluJo | chr17:82123196-82123429:-.alignment |
| chr17:82125254-82126245:- | ENST00000389641.7 | ENSG00000176155.17 | CCDC57 | intronic | AluSz,AluSq2,AluJo,A-rich | chr17:82125254-82126245:-.alignment |
| chr17:82125254-82126245:- | ENST00000392345.5 | ENSG00000176155.17 | CCDC57 | intronic | AluSz,AluSq2,AluJo,A-rich | chr17:82125254-82126245:-.alignment |
| chr17:82125254-82126245:- | ENST00000392346.5 | ENSG00000176155.17 | CCDC57 | intronic | AluSz,AluSq2,AluJo,A-rich | chr17:82125254-82126245:-.alignment |
| chr17:82125254-82126245:- | ENST00000392347.4 | ENSG00000176155.17 | CCDC57 | intronic | AluSz,AluSq2,AluJo,A-rich | chr17:82125254-82126245:-.alignment |
| chr17:82125254-82126245:- | ENST00000419322.5 | ENSG00000176155.17 | CCDC57 | intronic | AluSz,AluSq2,AluJo,A-rich | chr17:82125254-82126245:-.alignment |
| chr17:82125254-82126245:- | ENST00000583593.2 | ENSG00000176155.17 | CCDC57 | intronic | AluSz,AluSq2,AluJo,A-rich | chr17:82125254-82126245:-.alignment |
| chr17:82130146-82130380:- | ENST00000483145.1 | ENSG00000176155.17 | CCDC57 | ncRNA_intronic | AluSx1,AluJb | chr17:82130146-82130380:-.alignment |
| chr17:82145041-82145534:- | ENST00000582040.1 | ENSG00000176155.17 | CCDC57 | ncRNA_intronic | AluSx,AluSx1 | chr17:82145041-82145534:-.alignment |
| chr17:82185407-82187204:- | ENST00000389641.7 | ENSG00000176155.17 | CCDC57 | intronic | FLAM_C,AluJr4,AluJb,AluSc8 | chr17:82185407-82187204:-.alignment |
| chr17:82185407-82187204:- | ENST00000392343.3 | ENSG00000176155.17 | CCDC57 | intronic | FLAM_C,AluJr4,AluJb,AluSc8 | chr17:82185407-82187204:-.alignment |
| chr17:82185407-82187204:- | ENST00000392347.4 | ENSG00000176155.17 | CCDC57 | intronic | FLAM_C,AluJr4,AluJb,AluSc8 | chr17:82185407-82187204:-.alignment |
| ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
| ENSG00000176155.17,CCDC57 | BRCA | EAG | T_cells_CD4_memory_activated | 3.0941e-02 | 0.1566 |  |
| ENSG00000176155.17,CCDC57 | CESC | EAG | B_cells_memory | 2.3076e-02 | 0.4527 |  |
| ENSG00000176155.17,CCDC57 | COAD | EAG | Dendritic_cells_activated | 3.0288e-03 | 0.6146 |  |
| chr17:82109552-82112295:- | ESCA | EER | T_cells_regulatory_(Tregs) | 7.5738e-03 | -0.2929 | .chr17_82109552-82112295_-.png) |
| chr17:82113704-82113883:- | ESCA | EER | Mast_cells_resting | 2.5701e-03 | 0.3953 |  |
| chr17:82115465-82116118:- | ESCA | EER | NK_cells_resting | 1.6049e-03 | -0.3925 |  |
| chr17:82123196-82123429:- | ESCA | EER | Eosinophils | 2.2183e-02 | 0.4306 |  |
| ENSG00000176155.17,CCDC57 | ESCA | EAG | Mast_cells_resting | 2.6847e-02 | 0.2083 |  |
| chr17:82109552-82112295:- | KIRP | EER | T_cells_CD4_memory_activated | 5.9623e-05 | 0.6404 |  |
| chr17:82185407-82187204:- | KIRP | EER | NK_cells_resting | 6.5558e-03 | 0.5193 |  |
| ENSG00000176155.17,CCDC57 | KIRP | EAG | T_cells_CD4_memory_activated | 2.4360e-03 | 0.3812 |  |
| ENSG00000176155.17,CCDC57 | LAML | EAG | B_cells_memory | 2.1581e-02 | -0.2420 |  |
| chr17:82109552-82112295:- | LUAD | EER | Plasma_cells | 4.3370e-02 | -0.2015 |  |
| ENSG00000176155.17,CCDC57 | LUAD | EAG | T_cells_follicular_helper | 2.2955e-02 | -0.2129 |  |
| ENSG00000176155.17,CCDC57 | LUSC | EAG | T_cells_CD4_memory_resting | 7.5471e-03 | 0.3735 |  |
| chr17:82109552-82112295:- | OV | EER | Macrophages_M0 | 4.7227e-02 | -0.1879 |  |
| chr17:82115465-82116118:- | OV | EER | NK_cells_activated | 7.0077e-03 | 0.3365 |  |
| ENSG00000176155.17,CCDC57 | OV | EAG | NK_cells_activated | 3.7800e-02 | 0.1810 |  |
| ENSG00000176155.17,CCDC57 | PRAD | EAG | Dendritic_cells_resting | 1.1685e-02 | 0.4867 |  |
| chr17:82123196-82123429:- | STAD | EER | NK_cells_resting | 4.9570e-04 | 0.5580 |  |
| ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
| ENSG00000176155.17,CCDC57 | BRCA | GSVA_HALLMARK_PROTEIN_SECRETION | EAG | 1.3445e-02 | 0.1790 |  |
| chr17:82109552-82112295:- | BRCA | GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE | EER | 1.5450e-02 | 0.1942 |  |
| ENSG00000176155.17,CCDC57 | CESC | GSVA_HALLMARK_KRAS_SIGNALING_DN | EAG | 3.2664e-03 | 0.5648 |  |
| chr17:82113704-82113883:- | ESCA | GSVA_HALLMARK_CHOLESTEROL_HOMEOSTASIS | EER | 3.4891e-02 | 0.2825 |  |
| ENSG00000176155.17,CCDC57 | ESCA | GSVA_HALLMARK_MITOTIC_SPINDLE | EAG | 1.8909e-02 | -0.2205 |  |
| chr17:82109552-82112295:- | ESCA | GSVA_HALLMARK_KRAS_SIGNALING_DN | EER | 8.5933e-03 | 0.2884 |  |
| chr17:82115465-82116118:- | ESCA | GSVA_HALLMARK_MITOTIC_SPINDLE | EER | 3.2000e-02 | -0.2727 |  |
| ENSG00000176155.17,CCDC57 | LAML | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 5.5061e-03 | 0.2903 |  |
| chr17:82109552-82112295:- | LAML | GSVA_HALLMARK_MITOTIC_SPINDLE | EER | 1.2344e-02 | -0.2857 |  |
| ENSG00000176155.17,CCDC57 | LUAD | GSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | EAG | 2.7685e-02 | 0.2063 |  |
| ENSG00000176155.17,CCDC57 | LUSC | GSVA_HALLMARK_IL6_JAK_STAT3_SIGNALING | EAG | 1.3710e-05 | 0.5730 |  |
| ENSG00000176155.17,CCDC57 | OV | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EAG | 1.2347e-04 | 0.3280 |  |
| chr17:82109552-82112295:- | OV | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EER | 6.3255e-03 | 0.2566 |  |
| chr17:82115465-82116118:- | OV | GSVA_HALLMARK_MYC_TARGETS_V1 | EER | 3.8575e-04 | 0.4336 |  |
| ENSG00000176155.17,CCDC57 | PRAD | GSVA_HALLMARK_KRAS_SIGNALING_DN | EAG | 4.2189e-03 | 0.5422 |  |
| chr17:82115465-82116118:- | STAD | GSVA_HALLMARK_PI3K_AKT_MTOR_SIGNALING | EER | 8.3330e-05 | 0.3209 |  |
| chr17:82123196-82123429:- | STAD | GSVA_HALLMARK_ANDROGEN_RESPONSE | EER | 5.5240e-04 | 0.5542 |  |
| ENSG00000176155.17,CCDC57 | STAD | GSVA_HALLMARK_ADIPOGENESIS | EAG | 1.1798e-02 | 0.1739 |  |
| ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
| ENSG00000176155.17,CCDC57 | BLCA | BMS.754807 | EAG | 1.5031e-04 | -0.6658 |  |
| ENSG00000176155.17,CCDC57 | BRCA | CEP.701 | EAG | 3.9380e-02 | 0.1496 |  |
| chr17:82109552-82112295:- | BRCA | Axitinib | EER | 1.4871e-02 | 0.1960 |  |
| ENSG00000176155.17,CCDC57 | CESC | GNF.2 | EAG | 2.7545e-04 | -0.6664 |  |
| ENSG00000176155.17,CCDC57 | COAD | Epothilone.B | EAG | 3.6788e-03 | 0.6048 |  |
| chr17:82113704-82113883:- | ESCA | CMK | EER | 1.0808e-02 | 0.3381 |  |
| ENSG00000176155.17,CCDC57 | ESCA | Gefitinib | EAG | 2.3946e-04 | -0.3405 |  |
| chr17:82109552-82112295:- | ESCA | AZD.0530 | EER | 1.6579e-04 | -0.4042 |  |
| chr17:82115465-82116118:- | ESCA | AZD.2281 | EER | 3.8392e-03 | -0.3620 |  |
| chr17:82145041-82145534:- | ESCA | Midostaurin | EER | 6.9314e-03 | -0.4058 |  |
| ENSG00000176155.17,CCDC57 | KIRC | AG.014699 | EAG | 9.9220e-03 | 0.4425 |  |
| ENSG00000176155.17,CCDC57 | KIRP | BI.D1870 | EAG | 5.4880e-03 | -0.3514 |  |
| chr17:82109552-82112295:- | KIRP | AZD8055 | EER | 2.9213e-03 | -0.5019 |  |
| chr17:82185407-82187204:- | KIRP | BMS.754807 | EER | 2.1936e-03 | -0.5735 |  |
| ENSG00000176155.17,CCDC57 | LAML | Lenalidomide | EAG | 8.7009e-05 | 0.4017 |  |
| chr17:82109552-82112295:- | LAML | GDC0941 | EER | 1.3395e-03 | 0.3614 |  |
| chr17:82109552-82112295:- | LUAD | Gefitinib | EER | 1.0893e-02 | -0.2536 |  |
| ENSG00000176155.17,CCDC57 | LUSC | CI.1040 | EAG | 4.7255e-04 | -0.4762 |  |
| ENSG00000176155.17,CCDC57 | OV | BMS.509744 | EAG | 1.2581e-04 | -0.3276 |  |
| chr17:82109552-82112295:- | OV | ABT.263 | EER | 4.3511e-03 | 0.2675 |  |
| chr17:82115465-82116118:- | OV | DMOG | EER | 1.5790e-05 | 0.5149 |  |
| ENSG00000176155.17,CCDC57 | PRAD | AS601245 | EAG | 2.1802e-02 | -0.4478 |  |
| chr17:82123196-82123429:- | STAD | ABT.263 | EER | 5.3861e-03 | 0.4604 |  |
| ENSG00000176155.17,CCDC57 | STAD | BIRB.0796 | EAG | 9.4402e-04 | 0.2271 |  |
| chr17:82109552-82112295:- | STAD | Cyclopamine | EER | 3.9238e-02 | -0.1877 |  |